<?xml version="1.0" encoding="UTF-8"?>
<p>Immunoglobulins are purified blood products from the human body, containing a large number of antibodies, which interact with antigens to neutralize and kill bacteria and viruses. Under the action of large doses, they can also remove immune complexes in the human body and be used in combination with antiviral drugs, which can improve the efficacy for the infection of some serious viral diseases. Therefore, the application of immunoglobulins in treating COVID-19 is worthy of clinical promotion. Patients with COVID-19 can have natural antibodies, and it is necessary to consider convalescent plasma therapy when available. The S protein of SARS-COV-2 has a unique Flyn-like cleavage site (RRAR),
 <sup>[
  <xref rid="R51" ref-type="bibr">51</xref>]
 </sup> which has potential significance in studying its pathogenicity and developing drugs such as vaccines.
</p>
